Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03639948
Title Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer (NeoPACT)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Kansas Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Kansas Cancer Center (KUCC) Fairway Kansas 66205 United States Details
The University of Kansas Cancer Center, West Clinic Kansas City Kansas 66112 United States Details
The University of Kansas Cancer Center, Westwood Campus Kansas City Kansas 66205 United States Details
University of Kansas Cancer Center Kansas City Kansas 66205 United States Details
The University of Kansas Cancer Center, Overland Park Clinic Overland Park Kansas 66210 United States Details
The University of Kansas Cancer Center, North Clinic Kansas City Missouri 64154 United States Details
The University of Kansas Cancer Center, Lee's Summit Clinic Lee's Summit Missouri 64064 United States Details
The University of Kansas Medical Center North Kansas City Missouri 64116 United States Details
Texas Oncology- Baylor Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field